Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSULET CORPORATION

(PODD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SVB Leerink Adjusts Price Target on Insulet to $350 from $300, Keeps Outperform Rating

11/05/2021 | 10:22am EST


ę MT Newswires 2021
All news about INSULET CORPORATION
01/12CORRECTING and REPLACING Insulet to Announce Fourth Quarter and Full Year 2021 Financia..
BU
2021Berenberg Bank Terminates Coverage on a Number of Companies Due to Analysts' Departures..
MT
2021Insulet to Present at Nasdaq's 45th Investor Conference
AQ
2021Insulet to Present at Nasdaq's 45th Investor Conference
BU
2021INSIDER SELL : Insulet
MT
2021Raymond James Adjusts Price Target on Insulet to $329 from $285, Keeps Outperform Ratin..
MT
2021UBS Lifts Insulet's Price Target to $325 From $267 on Sales Estimates; Neutral Rating K..
MT
2021Berenberg Bank Adjusts Insulet's Price Target to $295 From $277, Maintains Hold Rating
MT
2021SVB Leerink Adjusts Price Target on Insulet to $350 from $300, Keeps Outperform Rating
MT
2021INSULET CORP Management's Discussion and Analysis of Financial Condition and Results o..
AQ
More news
Analyst Recommendations on INSULET CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 091 M - -
Net income 2021 13,4 M - -
Net Debt 2021 333 M - -
P/E ratio 2021 1 200x
Yield 2021 -
Capitalization 16 739 M 16 739 M -
EV / Sales 2021 15,7x
EV / Sales 2022 13,3x
Nbr of Employees 1 900
Free-Float 99,5%
Chart INSULET CORPORATION
Duration : Period :
Insulet Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSULET CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 242,71 $
Average target price 310,38 $
Spread / Average Target 27,9%
EPS Revisions
Managers and Directors
Shacey Petrovic President, Chief Executive Officer & Director
Wayde Dwight McMillan Chief Financial Officer, Treasurer & Executive VP
Timothy J. Scannell Independent Chairman
Trang Ly Senior Vice President & Medical Director
Charles Alpuche Chief Operations Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
INSULET CORPORATION-8.78%16 739
ABBOTT LABORATORIES-8.94%219 790
MEDTRONIC PLC4.93%145 952
BECTON, DICKINSON AND COMPANY4.43%74 858
HOYA CORPORATION-9.21%50 017
DEXCOM, INC.-16.69%43 357